Semaglutide Weight Loss Doctor in Stamford, CT: Greenwich MD offers physician-supervised GLP-1 therapy with comprehensive bloodwork, hormone optimization, and ongoing medical monitoring so patients lose weight safely and keep it off. Full Medical Weight Loss Program details

Medically reviewed by Susana Querido, MD, Triple Board-Certified in Family Medicine, Aesthetic Medicine, and Anti-Aging & Regenerative Medicine. Medical Director, Greenwich MD.
Semaglutide has changed the conversation around medically supervised weight loss, and patients across Fairfield County are searching for a qualified semaglutide doctor in Stamford, CT who can deliver this therapy responsibly. At Greenwich MD, located at 1351 Washington Boulevard, Suite 803, Stamford, CT 06902, Dr. Susana Querido personally evaluates every candidate, orders a complete diagnostic workup before the first dose, calibrates dosing around each patient’s metabolism and hormonal status, and provides the kind of continuity that mail-order telehealth platforms simply can’t replicate. The result isn’t just a number on a scale; it’s a medically documented, physician-monitored process designed to produce lasting fat loss rather than a short-term dip followed by rebound weight gain.
Below is a fast overview of what patients can expect when they choose Greenwich MD for semaglutide therapy in the Stamford area.
Semaglutide is a powerful GLP-1 receptor agonist originally studied for type 2 diabetes and later approved in higher doses for chronic weight management. Its mechanism, suppressing appetite and slowing gastric emptying, is well understood, but its interaction with a patient’s existing thyroid function, cortisol levels, insulin sensitivity, and cardiovascular history is not something an algorithm can safely parse. Unsupervised or minimally supervised semaglutide use, the kind offered by some telehealth apps without in-person evaluation, has been linked to muscle mass loss, nutritional deficiencies, and rebound weight gain once the drug is stopped. When a physician who knows the patient’s full picture is involved from day one, those risks shrink considerably because dosing, monitoring intervals, and supportive therapies can be adjusted in real time. Patients concerned about weight gain who want to understand its root causes before starting any medication will find that Greenwich MD’s weight gain evaluation lays the necessary groundwork for a safe, effective semaglutide plan.
Triple Board Certification: Dr. Susana Querido holds triple board certification in Family Medicine, Aesthetic Medicine, and Anti-Aging and Regenerative Medicine. That combination matters for semaglutide patients because weight loss isn’t a single-system problem. It involves metabolic health, hormonal balance, and long-term lifestyle sustainability, all areas that fall squarely within Dr. Querido’s clinical training. She evaluates patients through each of those lenses before recommending GLP-1 therapy, which means the prescription is part of a broader medical strategy rather than an isolated quick fix.
Continuity of Care: Greenwich MD does not delegate patient care to mid-level providers. Every consultation, every follow-up, and every dosing decision is handled by Dr. Querido personally. For semaglutide patients, that continuity is clinically significant. Dose escalation schedules need to be individualized, side effects like nausea or fatigue need to be assessed by someone who knows the patient’s history, and lab values need to be interpreted in context. Patients who’ve tried telehealth semaglutide programs frequently report that they never spoke to the same person twice; that’s not the experience at Greenwich MD.
Integrative Approach: Dr. Querido integrates hormonal and nutritional evaluation into every weight loss plan because the data consistently shows that unaddressed thyroid dysfunction, low testosterone, or estrogen imbalance can blunt the effectiveness of even the best GLP-1 protocol. “I want to know why a patient is struggling to lose weight before I reach for any prescription,” she has noted. “Semaglutide is a remarkable tool, but it works best when the rest of the metabolic picture is optimized at the same time.” That philosophy sets Greenwich MD apart from providers who treat semaglutide as a standalone solution.
Greenwich MD offers semaglutide therapy within a tiered, physician-designed framework. The appropriate option depends on a patient’s starting weight, metabolic labs, hormone status, and personal health goals, all of which are assessed during the initial consultation.
For patients whose lab work reveals no significant hormonal imbalances, Dr. Querido may initiate a structured semaglutide monotherapy protocol. This involves a gradual dose escalation starting at the lowest effective weekly dose, with blood glucose, lipid panel, and kidney function monitored at defined intervals. Nutritional guidance is provided alongside the prescription to preserve lean muscle mass and prevent the micronutrient depletion that can accompany rapid caloric reduction. The goal is steady, consistent fat loss over a clinically appropriate timeframe.
When initial testing through hormone replacement therapy evaluation identifies imbalances in thyroid hormones, cortisol, testosterone, or estrogen, Dr. Querido builds a combined protocol that addresses both the GLP-1 pathway and the hormonal environment simultaneously. Patients who’ve stalled on semaglutide elsewhere often find that correcting a sluggish thyroid or restoring testosterone to optimal range is the missing piece that allows consistent weight loss to resume. This integrated approach is one of Greenwich MD’s most meaningful clinical differentiators.
Some patients benefit from a more comprehensive support structure alongside their semaglutide prescription. Greenwich MD can incorporate a formal nutritional evaluation to identify dietary patterns, absorption issues, or macronutrient imbalances that may be interfering with fat metabolism. This layer of support is particularly valuable for patients with a history of yo-yo dieting, those recovering from long-term caloric restriction, or anyone whose previous weight loss attempts have plateaued despite strong compliance.
Understanding the structure of a semaglutide appointment at Greenwich MD helps patients arrive prepared and know what they’ll walk away with at each stage.
| Stage | What’s Included | Time |
|---|---|---|
| Initial Consultation | Medical history review, weight loss history, physical assessment, lab orders | 45 to 60 min |
| Lab Review Visit | Bloodwork and hormone panel results reviewed, personalized treatment plan finalized | 20 to 30 min |
| Treatment Initiation | First semaglutide dose, injection training, nutritional guidance provided | 20 to 30 min |
| Follow-Up Monitoring | Weight and body composition check, labs as indicated, dose adjustment if needed | 20 min (monthly) |
| Maintenance Planning | Weaning protocol, rebound prevention strategy, long-term metabolic support plan | 30 min |
Semaglutide is a prescription medication with a specific clinical profile. Dr. Querido uses the initial consultation and lab results to determine whether a patient is an appropriate candidate before any prescription is written.
Semaglutide isn’t appropriate for everyone. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 are not candidates. Pregnancy, active pancreatitis, and certain gastrointestinal conditions may also be contraindications. Dr. Querido reviews each patient’s complete medical history to rule out these factors before any prescription is issued.
Patients in Stamford, Greenwich, Darien, New Canaan, Westport, and Norwalk who are ready to explore physician-supervised semaglutide therapy can schedule a consultation with Dr. Susana Querido at Greenwich MD, located at 1351 Washington Boulevard, Suite 803, Stamford, CT 06902. The first step is a comprehensive evaluation, not a prescription pad, because lasting weight loss starts with understanding exactly what’s driving the problem.
Our Stamford clinic at 1351 Washington Boulevard serves patients throughout Fairfield County. Most nearby communities are within a 15-minute drive:
The table below outlines what to expect at each stage of your visit. Costs are confirmed during your consultation based on your individual treatment plan.
Coverage for GLP-1 medications varies significantly by insurance plan and diagnosis. Some plans cover semaglutide when prescribed for type 2 diabetes but not for weight management alone. Greenwich MD’s team can provide documentation to support an insurance inquiry, but patients should contact their carrier directly to confirm their specific benefits before starting treatment.
During the evaluation phase, patients typically attend two appointments within the first two weeks. Once treatment begins, monthly follow-up visits of roughly 20 minutes are standard. Patients who require hormone optimization or additional lab monitoring may have slightly more frequent visits early in the program. Dr. Querido designs the schedule around each patient’s clinical needs rather than a one-size-fits-all calendar.
Semaglutide has been studied extensively in large clinical trials and is FDA-approved for chronic weight management in appropriate candidates. Like any prescription medication, it carries potential risks and is contraindicated in certain populations. At Greenwich MD, safety is managed through pre-treatment lab work, ongoing bloodwork monitoring, and direct physician oversight at every step. Patients are never simply handed a prescription and left to self-manage.
Generally, adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related health condition such as high blood pressure or prediabetes, may qualify. Ideal candidates are also committed to monthly monitoring visits and willing to pair medication with nutritional and lifestyle guidance. Dr. Querido confirms candidacy only after reviewing complete bloodwork and a full medical history, so the consultation is an essential first step.
The most common early side effects are nausea, mild fatigue, and reduced appetite, particularly during dose escalation. Most patients find these symptoms manageable and temporary. Dr. Querido discusses the full side-effect profile at the initiation visit and adjusts the escalation schedule if tolerance is a concern. Patients are given direct contact information for the office so any unexpected symptoms can be addressed promptly rather than waiting for the next scheduled visit.
Yes. Greenwich MD’s Medical Weight Loss Program includes options beyond GLP-1 therapy, such as hormone optimization and targeted nutritional support. For some patients, correcting a thyroid imbalance or addressing a nutritional deficiency produces meaningful weight loss without requiring a GLP-1 medication at all. Dr. Querido evaluates the full clinical picture first and recommends the approach most likely to produce lasting results for that specific patient.
Telehealth semaglutide services typically issue prescriptions based on a brief online questionnaire with no in-person exam, no bloodwork, and no follow-up physician relationship. Greenwich MD takes the opposite approach: comprehensive lab testing before the first dose, in-person visits with Dr. Querido personally, hormone panel review, and a structured maintenance plan to prevent rebound weight gain after treatment ends. For patients who want a semaglutide doctor in Stamford, CT who’s accountable for the full outcome, not just the prescription, Greenwich MD is a meaningfully different option.
Your Beauty & Wellness Start Now!
Get notified about special offers and articles
Greenwich MD is an independent aesthetic medicine practice located at 1351 Washington Boulevard, Suite 803, Stamford, Connecticut 06902. Founded and led by Dr. Susana Querido, MD. Greenwich MD is not affiliated with Greenwich Medical Spa or any other practice with a similar name.